Chhattisgarh推出了鼓励措施和142英亩的药厂,以促进毒品制造和保健。 Chhattisgarh launches incentives and a 142-acre pharma park to boost drug manufacturing and healthcare.

Chhattisgarh正推动其成为印度中部最大的制药和生物技术枢纽的动力,推行高激励工业政策,在Nava Raipur开发一个142英亩的药用园。 Chhattisgarh is advancing its push to become a top pharmaceutical and biotechnology hub in central India by launching a high-incentive industrial policy and developing a 142-acre pharma park in Nava Raipur. 国家提供资本赠款,最高可达300克朗、12年电力免税、GST偿还款以及其他吸引投资的惠益。 The state offers capital grants up to ₹300 crore, 12-year electricity duty exemptions, GST reimbursement, and other benefits to attract investment. 超过1 000克朗的项目可能得到定制的奖励。 Projects over ₹1,000 crore may receive customized incentives. 在公私营伙伴关系下,该公园将设有插座和游戏基础设施,包括水、污水处理和废物管理。 The park will feature plug-and-play infrastructure, including water, effluent treatment, and waste management, under a public-private partnership. 国家拥有电力盈余、低关税,以及来自50 000多名年度毕业生和100多所药学院的人才库不断增加,国家的目标是加强制造业和保健基础设施,包括新医院和制药设施。 With a power surplus, low tariffs, and a growing talent pool from over 50,000 annual graduates and 100+ pharmacy colleges, the state aims to boost manufacturing and healthcare infrastructure, including new hospitals and pharmaceutical facilities.